Reports Q1 revenue $1.58B, consensus $1.61B. “Our first quarter results demonstrate disciplined execution and a continued focus on cost management in a dynamic macro environment,” said Michael Stubblefield, President and CEO. “While earnings and margin performance were in line with our plan, Lab Solutions revenue was impacted by reduced demand – particularly in our Education and Government end market – following recent policy changes. In our Bioscience Production segment, we delivered another quarter of growth in bioprocessing and order book momentum continues.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: